Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Mineralys Therapeutics (MLYS) Insider Trading & Ownership

Mineralys Therapeutics logo
$15.22 +0.01 (+0.07%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$15.22 -0.01 (-0.03%)
As of 08/28/2025 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Mineralys Therapeutics (NASDAQ:MLYS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
25.56%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$25.60M
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$4.31M
Get MLYS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Mineralys Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MLYS Insider Buying and Selling by Quarter

Mineralys Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/13/2025David Malcom RodmanInsiderSell11,365$12.93$146,949.45  
7/30/2025Adam Scott LevyCFOSell59,925$14.76$884,493.00  
7/29/2025Adam Scott LevyCFOSell807$14.00$11,298.00  
7/28/2025Adam Scott LevyCFOSell12,946$14.04$181,761.84  
7/14/2025David Malcom RodmanInsiderSell11,366$14.59$165,829.94  
7/11/2025Adam Scott LevyCFOSell10,758$14.45$155,453.10  
7/11/2025Jon CongletonCEOSell15,884$14.51$230,476.84  
5/14/2025David Malcom RodmanInsiderSell11,366$15.29$173,786.14  
4/14/2025David Malcom RodmanInsiderSell11,366$14.53$165,147.98  
4/11/2025Adam Scott LevyCFOSell10,757$12.06$129,729.42  
4/11/2025Jon CongletonCEOSell15,319$12.19$186,738.61  
4/1/2025David Malcom RodmanInsiderSell55,771$15.76$878,950.96  
3/13/2025Ra Capital Management, L.P.DirectorBuy1,296,296$13.50$17,499,996.00  
3/13/2025Samsara Biocapital Gp, LlcMajor ShareholderBuy600,000$13.50$8,100,000.00  
1/13/2025Adam Scott LevyCFOSell10,757$9.10$97,888.70  
1/13/2025Jon CongletonCEOSell18,333$9.06$166,096.98  
11/6/2024David Malcom RodmanInsiderSell25,482$15.03$382,994.46  
10/11/2024Adam Scott LevyCFOSell10,757$13.57$145,972.49  
10/11/2024Jon CongletonCEOSell15,271$13.52$206,463.92  
(Data available from 1/1/2013 forward)

MLYS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Mineralys Therapeutics includes Adam Scott Levy, Brian Taylor Slingsby, David Malcom Rodman, Hbm Healthcare Investments (Ca, Jon Congleton, Ra Capital Management, L.P., and Samsara Biocapital Gp, Llc. Learn more on insiders at MLYS.

25.56% of Mineralys Therapeutics stock is owned by insiders. Learn more on MLYS's insider holdings.

The following insiders have purchased MLYS shares in the last 24 months: Jon Congleton ($52,552.50), Ra Capital Management, L.P. ($17,499,996.00), and Samsara Biocapital Gp, Llc ($15,599,992.50).

Insiders have purchased a total of 2,458,351 MLYS shares in the last 24 months for a total of $33,152,541.00 bought.

The following insiders have sold MLYS shares in the last 24 months: Adam Scott Levy ($3,000,729.63), Brian Taylor Slingsby ($7,177,500.00), David Malcom Rodman ($1,923,033.93), and Jon Congleton ($1,415,086.46).

Insiders have sold a total of 1,015,009 Mineralys Therapeutics shares in the last 24 months for a total of $13,516,350.02 sold.

Mineralys Therapeutics Key Executives


Related Companies
Insider Tracking Tools
Insider Trading By Country
Latest Articles

This page (NASDAQ:MLYS) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel